# Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation

> **NCT03232450** · NA · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Foramen Ovale, Patent

## Interventions

- **DRUG:** Aspirin
- **DEVICE:** Cardiovascular Implantable Device (CIED)
- **DEVICE:** Gore Cardioform Septal Occluder

## Key facts

- **NCT ID:** NCT03232450
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding or enrollment
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03232450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03232450, "Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03232450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*